Safety & Recalls

Latest News

FDA Approves Vemlidy for Children with Hepatitis B
FDA Approves Vemlidy for Children with Hepatitis B

March 28th 2024

Vemlidy is now approved to treat patients 6 years and older with chronic hepatitis B virus infection.

Silicone Particles in Product Leads to Recall of Treprostinil
Silicone Particles in Product Leads to Recall of Treprostinil

March 14th 2024

AIGen-stock.adobe.com
FDA Warns About Malignancies from CAR-T Therapies

January 26th 2024

Product Mix Up Leads to Recall of Narcolepsy Drug Zenzedi
Product Mix Up Leads to Recall of Narcolepsy Drug Zenzedi

January 26th 2024

FDA Adds Boxed Warning to Prolia in Patients with Kidney Disease
FDA Adds Boxed Warning to Prolia in Patients with Kidney Disease

January 19th 2024

Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.